1. Home
  2. VRNA vs BANC Comparison

VRNA vs BANC Comparison

Compare VRNA & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • BANC
  • Stock Information
  • Founded
  • VRNA 2005
  • BANC 1941
  • Country
  • VRNA United Kingdom
  • BANC United States
  • Employees
  • VRNA N/A
  • BANC N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • BANC Major Banks
  • Sector
  • VRNA Health Care
  • BANC Finance
  • Exchange
  • VRNA Nasdaq
  • BANC Nasdaq
  • Market Cap
  • VRNA 3.4B
  • BANC 2.8B
  • IPO Year
  • VRNA 2017
  • BANC N/A
  • Fundamental
  • Price
  • VRNA $67.96
  • BANC $14.99
  • Analyst Decision
  • VRNA Strong Buy
  • BANC Buy
  • Analyst Count
  • VRNA 7
  • BANC 13
  • Target Price
  • VRNA $57.14
  • BANC $18.08
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • BANC 1.7M
  • Earning Date
  • VRNA 02-27-2025
  • BANC 01-23-2025
  • Dividend Yield
  • VRNA N/A
  • BANC 2.66%
  • EPS Growth
  • VRNA N/A
  • BANC N/A
  • EPS
  • VRNA N/A
  • BANC 0.52
  • Revenue
  • VRNA $5,624,000.00
  • BANC $960,394,000.00
  • Revenue This Year
  • VRNA N/A
  • BANC N/A
  • Revenue Next Year
  • VRNA $571.44
  • BANC $10.14
  • P/E Ratio
  • VRNA N/A
  • BANC $29.09
  • Revenue Growth
  • VRNA 1127.95
  • BANC 289.07
  • 52 Week Low
  • VRNA $11.39
  • BANC $11.88
  • 52 Week High
  • VRNA $68.64
  • BANC $18.08
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 76.88
  • BANC 36.73
  • Support Level
  • VRNA $62.24
  • BANC $15.50
  • Resistance Level
  • VRNA $65.50
  • BANC $16.00
  • Average True Range (ATR)
  • VRNA 2.78
  • BANC 0.44
  • MACD
  • VRNA 0.22
  • BANC -0.11
  • Stochastic Oscillator
  • VRNA 94.86
  • BANC 2.92

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: